Rongtai health(603579)
Search documents
其他家电板块12月26日跌0.91%,荣泰健康领跌,主力资金净流出4068.22万元
Zheng Xing Xing Ye Ri Bao· 2025-12-26 09:07
Group 1 - The other home appliance sector declined by 0.91% compared to the previous trading day, with Rongtai Health leading the decline [1] - On the same day, the Shanghai Composite Index closed at 3963.68, up 0.1%, while the Shenzhen Component Index closed at 13603.89, up 0.54% [1] - Key stock performance in the other home appliance sector included Rongjie Health at 5.32 with a rise of 0.57%, Jiajiahua at 7.66 with a drop of 1.42%, and Rongtai Health at 23.37 with a decline of 1.85% [1] Group 2 - The net outflow of main funds in the other home appliance sector was 40.68 million yuan, while retail investors saw a net inflow of 46.97 million yuan [1] - Specific fund flows showed Rongtai Health with a net outflow of 6.66 million yuan, Rongjie Health with a net outflow of 7.30 million yuan, and Jiajiahua with a significant net outflow of 26.72 million yuan [1]
上海荣泰健康科技股份有限公司关于签署募集资金三方监管协议的公告
Shang Hai Zheng Quan Bao· 2025-12-25 18:55
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 证券代码:603579 证券简称:荣泰健康 公告编号:2025-090 上海荣泰健康科技股份有限公司 关于签署募集资金三方监管协议的公告 一、募集资金基本情况 经中国证券监督管理委员会《关于核准上海荣泰健康科技股份有限公司公开发行可转换公司债券的批 复》(证监许可[2020]2139号)核准,上海荣泰健康科技股份有限公司(以下简称"公司")于2020年10 月30日公开发行600万张A股可转换公司债券(每张面值100元人民币),募集资金总额为人民币 600,000,000.00元,扣除各项发行费用6,017,670.96元(含税),实际募集资金净额为人民币 593,982,329.04元。上述募集资金已于2020年11月5日全部到位,并经中汇会计师事务所(特殊普通合 伙)出具中汇会验[2020]6483号验资报告验证。 公司募集资金投资项目的资金使用情况详见公司于2025年8月28日披露的《上海荣泰健康科技股份有限 公司关于2025年半年度募集资金存放与实际使用情况的专项报告》( ...
荣泰健康(603579) - 上海荣泰健康科技股份有限公司关于签署募集资金三方监管协议的公告
2025-12-25 09:15
证券代码:603579 证券简称:荣泰健康 公告编号:2025-090 上海荣泰健康科技股份有限公司 关于签署募集资金三方监管协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 2025 年 11 月 28 日、2025 年 12 月 17 日,公司分别召开第五届董事会第三 次会议、2025 年第三次临时股东会审议通过了《关于变更部分可转债募集资金 用途及可转债募集资金投资项目延期的议案》,公司拟缩减原募投项目"浙江 湖州南浔荣泰按摩椅制造基地项目"投资规模并进行延期,同时变更部分募投 项目为"智能按摩装备及关键零部件制造建设项目"、"汽车座椅舒适性系统 研发与制造建设项目"和"按摩控制系统与数据服务平台建设项目"。具体内 容详见公司 2025 年 12 月 2 日披露的《上海荣泰健康科技股份有限公司关于变 更部分可转债募集资金用途及可转债募集资金投资项目延期的公告》(公告编 号:2025-084)。 变更及延期后募集资金投资项目如下: | | | | | 单位:万元 | | --- | --- | --- | --- ...
其他家电板块12月25日涨3.98%,融捷健康领涨,主力资金净流出1717.39万元
Zheng Xing Xing Ye Ri Bao· 2025-12-25 09:07
Group 1 - The other home appliance sector increased by 3.98% compared to the previous trading day, with Rongjie Health leading the gains [1] - On the same day, the Shanghai Composite Index closed at 3959.62, up 0.47%, while the Shenzhen Component Index closed at 13531.41, up 0.33% [1] - The closing prices and percentage changes for key stocks in the other home appliance sector are as follows: Rongjie Health at 5.29 (+9.30%), Rongtai Health at 23.81 (+2.59%), and Aojiahua at 7.77 (-0.13%) [1] Group 2 - The net capital flow in the other home appliance sector showed a net outflow of 17.17 million yuan from institutional investors and 7.51 million yuan from retail investors, while individual investors had a net inflow of 24.69 million yuan [1] - Specific capital flows for key stocks are as follows: Rongjie Health had a net inflow of 9.88 million yuan from institutional investors, while it experienced a net outflow of 12.44 million yuan from retail investors [1] - Rongtai Health saw a net inflow of 0.76 million yuan from institutional investors, but a net outflow of 6.06 million yuan from retail investors [1]
荣泰健康:子公司开设专户并签署募集资金三方监管协议
Xin Lang Cai Jing· 2025-12-25 08:53
荣泰健康公告称,2020年10月30日,公司公开发行600万张A股可转债,募集资金6亿元,扣除费用后净 额为5.94亿元。2025年,公司变更部分可转债募集资金用途并延期项目。12月25日,公司及子公司上海 阿而泰机器人、上海摩忻智能科技、上海幸卓智能科技与保荐机构万和证券、中国农业银行上海长三角 一体化示范区支行签订《募集资金三方监管协议》。子公司已开设募集资金专项账户,截至12月24日, 各专户余额均为0元。 ...
上海荣泰健康科技股份有限公司关于使用可转债闲置募集资金进行现金管理的公告
Shang Hai Zheng Quan Bao· 2025-12-23 18:28
Core Viewpoint - The company plans to utilize idle funds from convertible bonds for cash management, aiming to enhance the efficiency of fund usage and generate financial returns for shareholders [2][4][12]. Investment Overview - **Investment Purpose**: The company intends to manage idle funds from convertible bonds without affecting the safety and intended use of the raised funds, thereby maximizing financial returns [4]. - **Investment Amount**: The amount allocated for cash management is RMB 100 million [4]. - **Funding Source**: The funds for this investment come from idle proceeds of the convertible bonds, which were approved by the China Securities Regulatory Commission and raised a total of RMB 600 million [5]. Investment Details - **Investment Type**: The company will invest in low-risk financial products with high liquidity [2][11]. - **Investment Method**: The cash management does not involve structured arrangements and does not constitute related-party transactions [8]. Recent Developments - The company has made changes to the use of some convertible bond proceeds, reducing the investment scale of the original project and postponing its timeline, while introducing new projects [6][7]. - As of September 30, 2025, the original project had a progress rate of 25.54%, and the new projects have not yet utilized the raised funds [7]. Impact on the Company - The cash management initiative is expected to improve investment returns and fund usage efficiency without impacting the company's main business operations or the progress of investment projects [12]. - The amount of RMB 100 million allocated for cash management is not expected to significantly affect the company's future operations, financial status, or cash flow [12]. Regulatory Compliance - The company has followed necessary approval procedures for the cash management initiative, ensuring compliance with relevant regulations and maintaining the integrity of the investment projects [12].
荣泰健康(603579) - 上海荣泰健康科技股份有限公司关于使用可转债闲置募集资金进行现金管理的公告
2025-12-23 11:46
证券代码:603579 证券简称:荣泰健康 公告编号:2025-089 上海荣泰健康科技股份有限公司 关于使用可转债闲置募集资金进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 已履行的审议程序:上海荣泰健康科技股份有限公司(以下简称"公司") 于 2025 年 4 月 23 日召开第四届董事会第二十一次会议、第四届监事会第十六次 会议,于 2025 年 5 月 14 日召开 2024 年年度股东大会,分别审议通过了《关于 公司 2025 年度使用可转债闲置募集资金进行现金管理的议案》,同意公司及子公 司使用最高不超过人民币 4.5 亿元的公开发行可转换公司债券(以下简称"可转 债")闲置募集资金适时投资安全性高、流动性好、低风险的理财产品或结构性 存款,授权期限为自公司 2024 年年度股东大会审议通过之日起 12 个月内。在上 述额度及授权期限内,资金可由公司、公司全资子公司共同滚动使用。具体内容 详见公司于 2025 年 4 月 24 日披露的《上海荣泰健康科技股份有限公司关于使用 可转 ...
其他家电板块12月23日跌0.73%,荣泰健康领跌,主力资金净流出1278.14万元
Zheng Xing Xing Ye Ri Bao· 2025-12-23 09:08
Group 1 - The core viewpoint indicates that the other home appliance sector experienced a decline of 0.73% on the previous trading day, with Rongtai Health leading the decline [1] - On the same day, the Shanghai Composite Index closed at 3919.98, reflecting a slight increase of 0.07%, while the Shenzhen Component Index closed at 13368.99, showing an increase of 0.27% [1] - The individual stock performance within the other home appliance sector is detailed in a table, highlighting the variations in stock prices [1] Group 2 - In terms of capital flow, the other home appliance sector saw a net outflow of 12.78 million yuan from main funds, while retail investors contributed a net inflow of 19.87 million yuan [2] - The table provided outlines the specific capital flow for individual stocks within the other home appliance sector [2]
荣泰健康跌2.01%,成交额4962.94万元,主力资金净流出414.48万元
Xin Lang Cai Jing· 2025-12-23 02:41
Core Viewpoint - Rongtai Health's stock has experienced fluctuations, with a year-to-date increase of 62.14%, but recent trends show a decline over the past 60 days, indicating potential volatility in the market [1][2]. Group 1: Stock Performance - As of December 23, Rongtai Health's stock price is 22.95 yuan per share, with a market capitalization of 4.667 billion yuan [1]. - The stock has seen a net outflow of 4.1448 million yuan in principal funds, with significant selling activity [1]. - Year-to-date, the stock has risen by 62.14%, but it has decreased by 6.63% over the past 20 days and 37.41% over the past 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Rongtai Health reported revenue of 1.148 billion yuan, a year-on-year decrease of 1.39%, and a net profit attributable to shareholders of 111 million yuan, down 22.24% year-on-year [2]. - The company has distributed a total of 880 million yuan in dividends since its A-share listing, with 316 million yuan distributed over the past three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders has increased by 15.59% to 15,500, while the average circulating shares per person have decreased by 0.82% to 13,145 shares [2]. - Notably, the fund "Fuguo New Emerging Industries Stock A" has exited the list of the top ten circulating shareholders [3].
上海荣泰健康科技股份有限公司关于使用可转债闲置募集资金现金管理赎回并继续进行现金管理的公告
Shang Hai Zheng Quan Bao· 2025-12-22 17:50
Core Viewpoint - The company, Shanghai Rongtai Health Technology Co., Ltd., has announced the use of idle funds from convertible bonds for cash management, aiming to enhance the efficiency of fund utilization and generate financial returns for shareholders [1][11]. Group 1: Cash Management Overview - The company has approved the use of up to RMB 450 million of idle funds from convertible bonds for cash management, with a focus on low-risk, high-liquidity financial products [1][11]. - The cash management aims to ensure that the safety of the raised funds is not compromised and that the intended use of the funds remains unchanged [2][11]. - The company has already redeemed RMB 130 million from investments in large certificates of deposit from Hangzhou Bank, yielding a total return of RMB 3.7017 million [2][11]. Group 2: Investment Details - The company has allocated RMB 30 million for cash management in the form of broker yield certificates, which meet the criteria of high safety and liquidity [3][5]. - The cash management products include various floating yield certificates issued by CITIC Securities, with investment amounts of RMB 10 million each and varying maturities [9][10]. - The cash management period for the purchased financial products will not exceed 12 months [5][11]. Group 3: Approval Process - The company conducted the necessary approval processes, including meetings of the board of directors and the supervisory board, to authorize the cash management plan [1][11]. - The supervisory board and the sponsor institution, Wanhe Securities Co., Ltd., have expressed their agreement with the cash management initiative [11]. Group 4: Impact on the Company - The cash management initiative is expected to improve the company's investment returns and fund utilization efficiency without affecting the main business operations or the progress of investment projects [11]. - The amount allocated for cash management, RMB 30 million, is not expected to have a significant impact on the company's future business, financial condition, operating results, or cash flow [11].